Michael Zinda - Nov 23, 2021 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role: EVP, Chief Science Officer
Signature: /s/ Steve Forte, Attorney-in-Fact
Stock symbol: RPTX
Transactions as of: Nov 23, 2021
Transactions value $: $91,948
Form type: 4
Date filed: 12/6/2021, 03:47 PM
Previous filing: Nov 17, 2021
Next filing: Jan 20, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPTX	Common Shares	Options Exercise	$6.75K	+4.12K	+773.36%	$1.64^*	4.66K	Nov 23, 2021	Direct
transaction	RPTX	Common Shares	Options Exercise	$19.4K	+11.9K	+254.69%	$1.64^*	16.5K	Nov 23, 2021	Direct
transaction	RPTX	Common Shares	Options Exercise	$40.4K	+19.6K	+118.65%	$2.06^*	36.1K	Nov 23, 2021	Direct
transaction	RPTX	Common Shares	Options Exercise	$25.4K	+10.5K	+29.01%	$2.43^*	46.6K	Nov 23, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RPTX	Employee Stock Option (right to buy)	Options Exercise	$0	-4.12K	-100%	$0.00^*	0	Nov 23, 2021	Common Shares	4.12K	$1.64	Direct	F1
transaction	RPTX	Employee Stock Option (right to buy)	Options Exercise	$0	-11.9K	-100%	$0.00^*	0	Nov 23, 2021	Common Shares	11.9K	$1.64	Direct	F1
transaction	RPTX	Employee Stock Option (right to buy)	Options Exercise	$0	-19.6K	-35.72%	$0.00	35.3K	Nov 23, 2021	Common Shares	19.6K	$2.06	Direct	F2
transaction	RPTX	Employee Stock Option (right to buy)	Options Exercise	$0	-10.5K	-7.05%	$0.00	138K	Nov 23, 2021	Common Shares	10.5K	$2.43	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Fully vested and exercisable.
F2	Twenty-five percent (25%) of the shares subject to the option vested on March 29, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
F3	Twenty-five percent (25%) of the shares subject to the option vested on December 16, 2020, and one thirty-ninth (1/39th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.